Magnetic resonance imaging of multiple sclerosis lesions. Measuring outcome in treatment trials.

Magnetic resonance-based measures of disease activity and progression are now routinely used in definitive phase III treatment trials of multiple sclerosis as important secondary outcome measures because they provide quantitative and objective confirmation of the primary clinical outcome measures. M...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Simon, J H
Format: Artigo
Idioma:Inglês
Publicat: 1996
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1303626/
https://ncbi.nlm.nih.gov/pubmed/8764625
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars